Heart disease and stroke statistics—2022 update: a report from the American Heart Association
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
[HTML][HTML] 2018 年中国成年居民高血压患病与控制状况研究
张梅， 吴静， 张笑， 胡彩红， 赵振平， 李纯， 黄正京… - 中华流行病学 …, 2021 - html.rhhz.net
目的了解中国≥ 18 岁居民高血压患病, 知晓, 治疗与控制以及血压测量现况. 方法2018
年中国慢性病及危险因素监测在全国31 个省(直辖区, 自治市) 的298 个县(区) …
年中国慢性病及危险因素监测在全国31 个省(直辖区, 自治市) 的298 个县(区) …
China stroke statistics 2019: a report from the National center for healthcare quality management in neurological diseases, China national clinical research center for …
China faces the greatest challenge from stroke in the world. The death rate for
cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million …
cerebrovascular diseases in China was 149.49 per 100 000, accounting for 1.57 million …
Quality of primary health care in China: challenges and recommendations
China has substantially increased financial investment and introduced favourable policies
for strengthening its primary health care system with core responsibilities in preventing and …
for strengthening its primary health care system with core responsibilities in preventing and …
Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) …
J Li, X Wang, J Chen, H Zhang, A Deng - JAMA cardiology, 2020 - jamanetwork.com
Importance Data are lacking whether patients with hypertension who are taking angiotensin-
converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have …
converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) have …
[PDF][PDF] SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
GM Kuster, O Pfister, T Burkard, Q Zhou… - European heart …, 2020 - academic.oup.com
OP-EHEA200234_online 1801..1803 Page 1 ..............................................................................
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with …
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with …
10 years of health-care reform in China: progress and gaps in Universal Health Coverage
In 2009, China launched a major health-care reform and pledged to provide all citizens with
equal access to basic health care with reasonable quality and financial risk protection. The …
equal access to basic health care with reasonable quality and financial risk protection. The …
Arterial hypertension
S Brouwers, I Sudano, Y Kokubo, EM Sulaica - The Lancet, 2021 - thelancet.com
Arterial hypertension is the most important contributor to the global burden of disease;
however, disease control remains poor. Although the diagnosis of hypertension is still based …
however, disease control remains poor. Although the diagnosis of hypertension is still based …
Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …
system blockers on angiotensin-converting enzyme 2 levels and activity in humans are …